Integra Lifesciences I v. Merck Kgaa.
This text of Integra Lifesciences I v. Merck Kgaa. (Integra Lifesciences I v. Merck Kgaa.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
Error: Bad annotation destination United States Court of Appeals for the Federal Circuit
02-1052, -1065
INTEGRA LIFESCIENCES I, LTD. and THE BURNHAM INSTITUTE,
Plaintiffs-Cross Appellants, and
TELIOS PHARMACEUTICALS, INC.,
Plaintiff-Appellee,
v.
MERCK KGaA,
Defendant-Appellant, and
THE SCRIPPS RESEARCH INSTITUTE and DR. DAVID A. CHERESH,
Defendants.
Donald R. Dunner, Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P., of Washington, DC, argued for defendant-appellant Merck KGaA. With him on the brief were Thomas H. Jenkins, David A. Manspeizer, and Rachel H. Townsend. Of counsel on the brief were M. Patricia Thayer, Heller Ehrman White & McAuliffe, LLP, of San Francisco, California; and William C. Rooklidge, Howrey Simon Arnold & White, LLP, of Irvine, California. Of counsel was Esther H. Lim, Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P., of Washington, DC.
Mauricio A. Flores, Campbell & Flores LLP, of San Diego, California, argued for plaintiffs-cross appellants Integra LifeSciences I, Ltd. and The Burnham Institute. With him on the brief was David M. Beckwith. Of counsel on the brief were Raphael V. Lupo, Mark G. Davis, and Natalia V. Blinkova, McDermott, Will & Emery, of Washington, DC. Of counsel was Donna M. Tanguay.
Appealed from: United States District Court for the Southern District of California
Senior Judge James M. Fitzgerald, District of Alaska United States Court of Appeals for the Federal Circuit
Plaintiffs-Cross Appellants,
and
Defendant-Appellant,
Before NEWMAN, RADER, and PROST, Circuit Judges.
ORDER
The court has received a certified copy of the judgment from the Clerk of the
Supreme Court of the United States in Merck KGaA v. Integra Lifesciences I, Ltd., No. 03-
1237. The Supreme Court vacated this court's judgment, which was reported at 331 F.3d
860 (Fed. Cir. 2003), and remanded for proceedings consistent with the Court's opinion. Upon consideration thereof,
IT IS ORDERED THAT:
(1) The mandate is hereby recalled and the appeal is reinstated.
(2) The case is returned to the original merits panel.
(3) New briefs shall be filed, with particular attention paid to the Supreme Court
decision.
(4) The appellants' principal brief shall be due within 60 days of the date of filing
of this order. The dates for filing the remaining briefs shall be in accordance with Fed. Cir.
R. 31(a). An original and 22 copies of all briefs shall be filed, and two copies shall be
served on opposing counsel. The court sua sponte allows amicus briefs.
FOR THE COURT
_Aug 17 2005__ _s/Jan Horbaly_____ Date Jan Horbaly Clerk
cc: Donald R. Dunner, Esq. Mauricio A. Flores, Esq.
02-1052, -1065 2
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Integra Lifesciences I v. Merck Kgaa., Counsel Stack Legal Research, https://law.counselstack.com/opinion/integra-lifesciences-i-v-merck-kgaa-cafc-2005.